Bank Of America Corp Arca Biopharma, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.71 - $4.0 $42 - $100	-25 Reduced 14.2%	151 $0
Q1 2024 May 15, 2024	BUY	$1.58 - $1.78 $210 - $236	133 Added 309.3%	176 $0
Q4 2023 Feb 14, 2024	BUY	$1.7 - $2.05 $20 - $24	12 Added 38.71%	43 $0
Q1 2023 May 12, 2023	SELL	$1.99 - $2.55 $67 - $86	-34 Reduced 52.31%	31 $0
Q4 2022 Feb 10, 2023	BUY	$1.86 - $25.8 $63 - $877	34 Added 109.68%	65 $0
Q1 2022 May 16, 2022	SELL	$1.77 - $2.49 $47 - $67	-27 Reduced 46.55%	31 $0
Q4 2021 Feb 08, 2022	SELL	$2.15 - $2.97 $101 - $139	-47 Reduced 44.76%	58 $0
Q3 2021 Nov 15, 2021	BUY	$2.77 - $3.74 $204 - $276	74 Added 238.71%	105 $0
Q2 2021 Sep 13, 2021	BUY	$3.06 - $3.9 $94 - $120	31 New	31 $0

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.